Source: MobiHealthNews exclusive — Jessica Hagen, October 14, 2026 · Investors: Redesign Health, Locke Health and KCRise Fund
Healthcare practices have spent decades investing in software that helps them collect revenue. Far fewer systems help them decide what to do with the cash after it arrives. Treso, a Kansas City startup backed by Redesign Health, is betting that the next financial operating system for independent physicians will connect both sides of the ledger: money earned, money collected, money spent and the liquidity needed to keep a practice operating.
In an October 14 exclusive reported by Jessica Hagen at MobiHealthNews, Treso disclosed $3.75 million in funding led by Redesign Health, with Locke Health and KCRise Fund participating. The company plans to launch in December 2026, offering a financial management platform aimed at independent physician practices.
Treso is not announcing a completed national rollout, a proven collections uplift or a new RCM services contract. It is a prelaunch financing announcement. Its significance lies in the architecture it is trying to build: a unified view of receivables, accounting, expense management, procurement, business intelligence, banking and related financial services.
Funding led by Redesign Health with participation from Locke Health and KCRise Fund. Treso plans to enter the market in December 2026. The company says its core platform will be free; pricing and eligibility for related financial products were not detailed in the announcement.
Most RCM software is oriented around the journey from encounter to payment: registration, eligibility, authorization, coding, claims, denials, A/R follow-up and posting. It answers an essential question: How do we get paid correctly?
Practice owners face a second question every day: What cash is available, what bills must be paid, and what can the business afford?
The gap between those questions matters. A physician group can report healthy billed revenue while experiencing a cash crunch because payer payments arrive late, payroll is due, suppliers require payment and the practice lacks a reliable forecast of collections. An RCM dashboard alone does not necessarily show whether the organization can safely hire another provider or open another location.
Treso's thesis is that financial management should not begin once claims have been posted. The same operating environment should help practices see receivables alongside expenditures, commitments and working-capital requirements.
That shifts the product category from conventional billing administration to financial orchestration for the physician practice.
According to MobiHealthNews, Treso began as an expense-management concept before broadening into a more complete financial platform. Its planned product includes a business-spending card, virtual cards assigned to individual vendors, configurable spending limits and AI-assisted matching of receipts to transactions.
It also plans spending analytics, which would help practices understand expense patterns and compare them with other practices. Collections and spending data are intended to inform additional cash-flow and expense-management tools. Treso reports that it has established banking partnerships to support financial offerings for providers.
That entry point is deliberate. Card spending and accounts-payable activity can generate a continuous stream of operational data, with practical use cases even before a full integration into claims and remittances is available.
For an independent physician group, the immediate value could be simpler reconciliation and better controls around vendor expenditures. The larger ambition is a finance platform that understands both sides of the business—not merely whether a purchase receipt matches a transaction, but how that expenditure relates to practice profitability and expected collections.
The RCM opportunity may extend beyond making cash arrive faster. It may include helping practices forecast, allocate and protect that cash. The company that can reliably connect payer collections with practice expenses has a different strategic position from a vendor that handles only claim submission or follow-up.
Treso says it intends to make its core product available free of charge. That is an unusual posture relative to traditional per-provider subscription software and should attract attention from vendors serving smaller independent practices.
Free software can reduce the perceived cost of adopting a new financial workflow. It may also help a new provider establish regular engagement and permissioned access to high-frequency financial activity.
But the economics of free software are not automatic. Healthcare fintech businesses can potentially monetize through financial products, payments, interchange, financing or premium services. MobiHealthNews does not establish which of those revenue streams Treso will use or the commercial terms of any banking product. Those are industry possibilities, not confirmed elements of Treso's model.
The key question is whether a no-cost entry product generates sufficient value to overcome the real cost of onboarding: accounting connections, data migration, financial controls, banking requirements, staff training and integration into whatever PM/EHR tools a practice already operates.
The most difficult part of the vision may not be issuing cards or categorizing purchases. It may be turning healthcare receivables into a reliable financial forecast.
Gross charges, submitted claims and expected reimbursement are not interchangeable. A practice's forward-looking cash model must account for payer contract terms, patient responsibility, denial patterns, adjustment behavior, timing differences and the possibility of recoupments.
For example, $100,000 in open A/R does not necessarily represent $100,000 in near-term cash. The real amount may depend on who owes it, how old the claims are, which denials remain actionable and whether the practice has accurate contracted-rate data.
A platform with deep payer-level payment outcomes can distinguish a likely collection from a nominal receivable. That could improve working-capital decisions and prevent a practice from spending against revenue it is unlikely to realize.
There is a significant implementation difference between importing an A/R aging report and producing a forecast that practice leadership can trust.
Most EHR, practice-management and RCM vendors already sit near financially valuable data: schedules, charge capture, claims, remittances, balances and patient payments. Yet financial operations commonly remain fragmented across those systems and separate accounting, banking and purchasing tools.
Treso is approaching the market from the opposite direction. It starts with practice spending and broader financial tools, with the ambition to use spending and collection signals together.
That creates a strategic tension for incumbent vendors. If financial-management products gain the owner's daily attention while RCM becomes a source of upstream data, part of the client relationship could shift away from the system that generates claims.
It would be premature to assume that happens. Integration barriers are real, and established PM/EHR vendors have access and workflow advantages that fintech startups do not. But it illustrates a larger competitive shift: the operating dashboard most valuable to the practice owner may not be the billing dashboard.
Consider what a mature platform could answer when it combines reliable collections and expense data:
These are potential capabilities of a connected financial operating system, not features independently confirmed to exist in Treso's initial launch. They illustrate the opportunity if transaction, reimbursement and expense data can be reconciled accurately over time.
Treso's launch will be meaningful only if independent practices can use the product without introducing another set of administrative tasks. RCAI would watch five things:
Those questions are essential precisely because the company's idea is compelling. Healthcare practices are financially complex small businesses. A well-designed financial platform could help remove that complexity, but only if it handles the difficult underlying data with precision.
Treso is an early-stage signal that the revenue cycle's next competitive frontier may be the practice's entire financial operating system.
The launch is not yet proof of adoption or ROI. What is noteworthy is the business model and starting point: free core financial software, expense workflows first, banking partnerships and a stated plan to connect collections with expenditures.
Traditional RCM products typically optimize how money comes in. Treso is exploring a broader proposition: helping independent practices understand what the money means once it arrives—and what decisions they can safely make before it does.
For operators, the prize is not an additional dashboard. It is a financially accurate, daily operating picture that links reimbursement, liquidity and expense management. If this category succeeds, the most important RCM platform may be the one that manages the money on both sides of the claim.
Independent coverage of healthcare finance, payments, AI, RCM and the businesses reshaping provider operations.
Original reporting: Jessica Hagen, “Exclusive: Treso raises $3.75M for financial software for healthcare,” MobiHealthNews, October 14, 2026. Funding, roadmap, participants and the December launch are based on MobiHealthNews' reporting. Strategic analysis and prospective use cases are independently developed by RevCycleAI; they are not claims of currently deployed functionality or proven ROI.